|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 405/06 | |
| C07D 401/06 | |||
| C07D 207/416 | |||
| A61K 31/4439 | |||
| A61K 31/4025 | |||
| A61P 3/10 | |||
| A61P 25/28 |
| (11) | Patento numeris | 1646626 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04749150.1 |
| Europos patento paraiškos padavimo data | 2004-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-04-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-07-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SE2004/001114 |
| Data | 2004-07-08 |
| (87) | Numeris | WO 2005/005417 |
| Data | 2005-01-20 |
| (30) | Numeris | Data | Šalis |
| 0316232 | 2003-07-11 | GB |
| (72) |
BOSTRÖM, Jonas, SE
BRICKMANN, Kay, SE
HOLM, Patrik, SE
SANDBERG, Pernilla, SE
SWANSON, Marianne, SE
WESTERLUND, Christer, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS |
| PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS |